Related Experiment Video

Updated: Jan 17, 2026

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals
07:30

The Muscle Cuff Regenerative Peripheral Nerve Interface for the Amplification of Intact Peripheral Nerve Signals

Published on: January 13, 2022

2.5K

Repetitive nerve stimulation normalization after FcRn inhibitor therapy in refractory myasthenia gravis: A case

Rajiv Wijesinghe1, Richard Yitong Shao1, Gaven Lin1

  • 1Neurophysiology and Neurology Departments, Westmead Hospital, Sydney, Australia.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|September 13, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Myasthenia gravisRepetitive nerve stimulationneonatal Fc receptor

More Related Videos

Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System12:19

Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System

Published on: January 20, 2012

27.5K
Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

1.5K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K